Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, indicating a routine update to the site or document version.
    Difference
    0.0%
    Check dated 2026-09-15T20:35:52.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5.
    Difference
    0.0%
    Check dated 2026-09-01T18:20:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5, indicating a minor update to the page.
    Difference
    0.0%
    Check dated 2026-08-11T14:40:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to a newer version, indicating a small update to the study record’s metadata. This does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-28T04:53:24.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page now shows a new revision number (v3.6.3) replacing the previous v3.6.2, indicating a page update. This update does not alter study content or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-07-06T16:31:01.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, signaling a newer build/version of the page. This reflects an update to the page infrastructure rather than alterations to study content.
    Difference
    0.0%
    Check dated 2026-06-29T08:28:17.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.